Replimune
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Replimune and other ETFs, options, and stocks.About REPL
Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer.
CEOSushil Patel
CEOSushil Patel
Employees479
Employees479
HeadquartersWoburn, Massachusetts
HeadquartersWoburn, Massachusetts
Founded2015
Founded2015
Employees479
Employees479
REPL Key Statistics
Market cap645.59M
Market cap645.59M
Price-Earnings ratio-2.28
Price-Earnings ratio-2.28
Dividend yield—
Dividend yield—
Average volume1.13M
Average volume1.13M
High today$8.83
High today$8.83
Low today$8.23
Low today$8.23
Open price$8.83
Open price$8.83
Volume1.13M
Volume1.13M
52 Week high$14.80
52 Week high$14.80
52 Week low$2.68
52 Week low$2.68
Stock Snapshot
Replimune(REPL) stock is priced at $8.39, giving the company a market capitalization of 645.59M. It carries a P/E multiple of -2.28.
On 2026-01-09, Replimune(REPL) stock traded between a low of $8.23 and a high of $8.83. Shares are currently priced at $8.39, which is +2.0% above the low and -5.0% below the high.
Replimune(REPL) shares are trading with a volume of 1.13M, against a daily average of 1.13M.
In the last year, Replimune(REPL) shares hit a 52-week high of $14.80 and a 52-week low of $2.68.
In the last year, Replimune(REPL) shares hit a 52-week high of $14.80 and a 52-week low of $2.68.
Analyst ratings
75%
of 8 ratingsBuy
75%
Hold
25%
Sell
0%
People also own
Based on the portfolios of people who own REPL. This list is generated using Robinhood data, and it’s not a recommendation.